Skip to main content
Global Edition
Thursday, March 28, 2024

Thursday 9/2 Insider Buying Report: BLFY, PAHC

Duration: 00:54s 0 shares 2 views

Thursday 9/2 Insider Buying Report: BLFY, PAHC
Thursday 9/2 Insider Buying Report: BLFY, PAHC

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

At Blue Foundry Bancorp, a filing with the SEC revealed that on Monday, Director Robert Thomas Goldstein purchased 17,500 shares of BLFY, at a cost of $13.56 each, for a total investment of $237,318.

So far Goldstein is in the green, up about 2.6% on their buy based on today's trading high of $13.92.

Blue Foundry Bancorp is trading off about 0.2% on the day Thursday.

Before this latest buy, Goldstein made one other buy in the past twelve months, purchasing $92,700 shares at a cost of $12.36 a piece.

And at Phibro Animal Health, there was insider buying on Monday, by Director E.

Thomas Corcoran who purchased 5,000 shares for a cost of $23.68 each, for a total investment of $118,400.

Phibro Animal Health is trading up about 5.2% on the day Thursday.

Corcoran was up about 7.8% on the buy at the high point of today's trading session, with PAHC trading as high as $25.53 at last check today.

You might like